首页> 外文会议>Proceedings of the 29th Annual Meeting of the Controlled Release Society >HPMA COPOLYMERS WITH HYDRAZONE-ATTACHED DOXORUBICIN ARE EFFICIENT IN THE TREATMENT OF MOUSE T CELL LYMPHOMA EL4
【24h】

HPMA COPOLYMERS WITH HYDRAZONE-ATTACHED DOXORUBICIN ARE EFFICIENT IN THE TREATMENT OF MOUSE T CELL LYMPHOMA EL4

机译:含羟基的阿霉素的HPMA共聚物可有效治疗小鼠T细胞淋巴瘤EL4

获取原文

摘要

The aim of the present work was to compare the in vivo effect of poly(HPMA) conjugates with hydrazone-attached doxorubicin on blood clearance and growth of mouse cancer EL4. The conjugates were synthesized with two different side chains (GG, GFLG), with lower (M_w~20 kDa) and higher (M_w~110 kDa) molecular weight, with or without targeted structure. We have concluded that hydrazone conjugates remained in blood circulation longer than free drug and had better therapeutic effect on mouse T cell lymphoma EL4 than free drug or PK1 conjugate.
机译:本工作的目的是比较聚(HPMA)偶联物与连接的阿霉素对小鼠癌EL4的血液清除和生长的体内作用。合成的结合物具有两条不同的侧链(GG,GFLG),分子量较低(M_w〜20 kDa),分子量较高(M_w〜110 kDa),具有或不具有目标结构。我们得出的结论是,缀合物在血液循环中的停留时间比游离药物更长,并且比游离药物或PK1缀合物对小鼠T细胞淋巴瘤EL4的治疗效果更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号